Smarter specialty spend in inflammatory care: Why adherence-focused models matter
Learn how adherence-focused specialty pharmacy care models reduce avoidable costs and improve outcomes in inflammatory care.
Read More
GLP-1s drive historic shift in traditional drug trend
GLP-1 medications drive unprecedented growth in traditional drug spending, surpassing specialty drug trends for the first time.
Read More
Express Scripts expands Patient Assurance Program to drive affordability and access to GLP-1s
Express Scripts will add GLP-1s for weight loss to the Patient Assurance Program (PAP), made possible by collaboration with Lilly and Novo Nordisk.
Read More
Evernorth Launches New Benefit Option That Drives Lower Net Cost for Weight Loss Medicines and Limits Patient Cost to No More Than $200 Per Month
• Patients can save as much as $3600 per year versus direct-to-consumer manufacturer programs, and out of pocket cost applies to their annual deductible • New offering helps employers meet growing ...
Read More
Most Favored Nation policy cannot succeed without the pharmacy benefit
Considering President Trump’s recent executive order, we examine the Most Favored Nation prescription drug pricing policy to the pharmacy benefit and discuss how removing PBMs – “the middleman” – is o...
Read More
Finding avenues to affordability for patients on specialty medications
Accredo has been helping patients access copay assistance programs for more than 10 years. Learn how copay assistance programs help patients access the care they need.
Read More